Eric Marsault,
Professor
After an undergraduate training at université Pierre et Marie Curie (Paris VI) and École Supérieure de Chimie Organique et Minérale (Paris), Eric Marsault obtained his Ph.D. at McGill University (Montreal, Qc, Canada) in 1996 with Pr George Just, then worked as a visiting scientist for Sanofi (Milan, Italy) prior to joining Université de Sherbrooke (Qc, Canada) as a postdoctoral fellow with Pr Pierre Deslongchamps. In 2000, he joined Néokimia (which later became Tranzyme Pharma) where he worked for 8 years as a researcher, group leader then director of medicinal chemistry. Throughout this time, the Tranzyme team matured then developed the first high throughput parallel platform to produce macrocyclic peptidomimetics, then optimized 2 clinical Ph.2 and Ph.3 candidates. In 2009, he joined Université de Sherbrooke as an Associate Professor and became Full Professor in 2015. His research focuses on the validation of emerging targets and the development of academic drug discovery, with a particular focus on peptidomimetics and macrocycles on targets such as GPCRs and transmembrane serine proteases for cardiovascular diseases, pain and infectious diseases. He is co-author of > 45 publications and co-inventor of > 35 patents. Since 2013 he is also chairman of the Institut de Pharmacologie de Sherbrooke, which focuses on the validation of emerging targets and the optimization of new drug candidates and diagnostic applications.
|
|
|
